Company Overview

American Oncology Network, Inc. (AONC) is a physician-led oncology services organization operating in the healthcare and oncology care delivery industries. The company focuses on supporting independent, community-based medical oncology practices by providing centralized management services, clinical infrastructure, and access to value-based care models. Its core mission is to enable physicians to remain independent while improving patient outcomes and practice sustainability in a shifting reimbursement and regulatory environment.

The company generates value by aligning clinical care delivery with operational scale, data-driven treatment pathways, and alternative payment models. American Oncology Network, Inc. primarily serves community oncology practices and their patient populations, positioning itself as an alternative to hospital-owned oncology networks. Founded in 2018, the company was established by practicing oncologists and healthcare executives in response to increasing consolidation in oncology care and has expanded through practice affiliations rather than direct ownership in many cases.

Business Operations

American Oncology Network, Inc. operates through integrated practice management, clinical pathway development, and value-based care enablement business lines. Revenue is generated through management services agreements with affiliated oncology practices, participation in oncology-focused alternative payment models, and administrative, technology, and revenue cycle management services. The company supports both medical oncology and hematology practices, with ancillary services such as in-office dispensing and care coordination depending on practice structure and state regulations.

Operations are primarily domestic, with activities concentrated in the United States. AON controls proprietary clinical pathways, centralized analytics, and operational platforms designed to support quality reporting, payer contracting, and cost management. Publicly available information indicates affiliations with numerous independently owned oncology practices, though the exact legal structure of each affiliation can vary. Data regarding joint ventures or equity ownership structures is limited; data inconclusive based on available public sources.

Strategic Position & Investments

The strategic direction of American Oncology Network, Inc. centers on scaling independent oncology care through value-based reimbursement participation, including models sponsored by the Centers for Medicare & Medicaid Services (CMS). Growth initiatives emphasize expanding its affiliated physician network, enhancing data and analytics capabilities, and increasing participation in downside-risk oncology payment programs.

The company has invested in clinical standardization tools, including AON Clinical Pathways, and care management infrastructure to support cost containment and quality measurement. While AON has announced practice affiliations and internal platform development, publicly disclosed information on major acquisitions or external equity investments is limited. No independently verified evidence of international investments or non-oncology portfolio companies was identified; data inconclusive based on available public sources.

Geographic Footprint

American Oncology Network, Inc. is headquartered in the United States and operates exclusively within the North American healthcare market. Its affiliated practices are distributed across multiple U.S. states, giving the company a broad but domestic geographic footprint focused on regional and community-based oncology care delivery.

The company does not publicly report operations, subsidiaries, or investments outside the United States. Its geographic influence is therefore tied to domestic healthcare policy, U.S. payer systems, and regional oncology market dynamics rather than global expansion.

Leadership & Governance

American Oncology Network, Inc. is physician-founded and maintains a leadership structure combining clinical and operational expertise. Governance emphasizes physician leadership, clinical autonomy, and alignment with value-based care principles. The leadership philosophy publicly articulated by the company focuses on preserving independent oncology practices while leveraging scale and data to improve care quality and financial sustainability.

Key executives publicly associated with the company include:

• Todd Schonherz – Chief Executive Officer
• Stephen Schleicher, MD – Founder & Chief Medical Officer
• Chad Bjerke – Chief Financial Officer

Public sources consistently identify these individuals in senior leadership roles. Information on additional executive officers or board composition is limited or varies across disclosures; data inconclusive based on available public sources.